Neutrophilic eccrine hidradenitis is an uncommon disease affecting the eccrine glands, leading to eccrine unit necrosis. It is most commonly seen in adults receiving cytarabine as a part of the induction chemotherapy for the treatment of hematological malignancy. The diagnosis of neutrophilic eccrine hidradenitis may signify that the patient has an underlying malignancy or relapse of previous malignancy. In newly diagnosed neutrophilic eccrine hidradenitis patients with no history of malignancy, the primary care provider should be notified, and age-appropriate cancer screening guidelines should be followed. This activity reviews the evaluation, treatment, and prognosis of neutrophilic eccrine hidradenitis and examines the role of the interprofessional team in evaluating and improving care for patients with this condition.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/25847
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.0 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Complex General Surgical Oncology, Dermatopathology, Hematology, Hospice & Palliative Medicine, Hospice and Palliative Medicine, Medical Oncology, Pediatric Hematology-Oncology